EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1

Hai-Xin Liu, Li Lian, Li-Li Hou, Cai-Xia Liu, Jin-Hong Ren, Yuan-Biao Qiao, Shi-Yuan Wen iD, Qing-Shan Li

Animal Models and Experimental Medicine · 2024

DOI: 10.1002/ame2.12434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Hai-Xin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Breast Neoplasms, Molecular Docking Simulation, Mice, Inbred BALB C. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanxi Province for Youths, Science and technology innovation ability cultivation program project of Shanxi University of Chinese Medicine, The immune regulation Chinese medicine research and development innovation team project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

According to traditional Chinese medicine (TCM), drugs supplementing the vital energy, Qi, can eliminate tumors by restoring host immunity. The objective of this study is to investigate the underlying immune mechanisms of anti‐tumor activity associated with Qi‐supplementing herbs, specifically the paired use of Huangqi and Danggui.

Methods

Analysis of compatibility regularity was conducted to screen the combination of Qi‐supplementing TCMs. Using the MTT assay and a transplanted tumor mice model, the anti‐tumor effects of combination TCMs were investigated in vitro and in vivo. High content analysis and flow cytometry were then used to evaluate cellular immunity, followed by network pharmacology and molecular docking to dissect the significant active compounds and potential mechanisms. Finally, the anti‐tumor activity and the mechanism of the active ingredients were verified by molecular experiments.

Results

There is an optimal combination of Huangqi and Danggui that, administered as an aqueous extract, can activate immunity to suppress tumor and is more effective than each drug on its own in vitro and in vivo. Based on network pharmacology analysis, PIK3R1 is the core target for the anti‐tumor immunity activity of combined Huangqi and Danggui. Molecular docking analysis shows 6 components of the combined Danggui and Huangqi extract (quercetin, jaranol, isorhamnetin, kaempferol, calycosin, and suchilactone) that bind to PIK3R1. Jaranol is the most important component against breast cancer. The suchilactone/jaranol combination and, especially, the suchilactone/kaempferol combination are key for immunity enhancement and the anti‐tumor effects of the extract.

Conclusions

The combination of Huangqi and Danggui can activate immunity to suppress breast cancer and is more effective than the individual drugs alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalBreast NeoplasmsMolecular Docking SimulationMice, Inbred BALB CAnimalsFemaleMiceHumansAstragalus propinquusCell Line, TumorUp-Regulation

Stichwörter der Autor:innen

DangguiHuangqianti‐tumorimmunity

Substanzen

Drugs, Chinese HerbalHuang Qi

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan, China.
  • Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Tai…
  • College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.

ORCID-Profile: Shi-Yuan Wen

Förderung

  • Natural Science Foundation of Shanxi Province for Youths
  • Science and technology innovation ability cultivation program project of Shanxi University of Chinese Medicine
  • The immune regulation Chinese medicine research and development innovation team project

Zitieren

APA

Liu, H. X., Lian, L., Hou, L. L., Liu, C. X., Ren, J. H., Qiao, Y. B., Wen, S. Y., & Li, Q. S. (2024). Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12434

Vancouver

Liu HX, Lian L, Hou LL, Liu CX, Ren JH, Qiao YB, et al. Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12434

BibTeX
@article{Liu2024,
  author = {Liu, Hai-Xin and Lian, Li and Hou, Li-Li and Liu, Cai-Xia and Ren, Jin-Hong and Qiao, Yuan-Biao and Wen, Shi-Yuan and Li, Qing-Shan},
  title = {Herb pair of Huangqi‐Danggui exerts anti‐tumor immunity to breast cancer by upregulating PIK3R1},
  journal = {Animal Models and Experimental Medicine},
  year = {2024},
  doi = {10.1002/ame2.12434}
}
Kostenlos starten →